Signal Advisors Wealth LLC Has $832,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Signal Advisors Wealth LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,594 shares of the medical equipment provider’s stock after purchasing an additional 173 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Intuitive Surgical were worth $832,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Mark Sheptoff Financial Planning LLC bought a new stake in Intuitive Surgical in the second quarter valued at about $37,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter worth about $38,000. Finally, DT Investment Partners LLC lifted its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $538.88 on Wednesday. The business’s fifty day moving average price is $537.05 and its two-hundred day moving average price is $496.50. The firm has a market capitalization of $191.94 billion, a price-to-earnings ratio of 86.64, a PEG ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Mizuho upped their price objective on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Royal Bank of Canada upped their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Citigroup lifted their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. BTIG Research upped their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.